This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Clexio Biosciences Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Ari Gershon: Innovator in Neuropsychiatric Treatment
Introduction
Ari Gershon is a notable inventor based in Jerusalem, Israel. She has made significant contributions to the field of neuropsychiatry through her innovative work. Her research focuses on the safe and effective administration of esketamine, a compound that has shown promise in treating various neuropsychiatric and neurological conditions.
Latest Patents
Ari Gershon holds a patent for a dosage regime with esketamine for treating neuropsychiatric or neurological conditions. The present invention provides a method for safe and efficacious administration of esketamine. This patent highlights her commitment to advancing treatment options for patients suffering from these challenging conditions. She has 1 patent to her name.
Career Highlights
Ari is currently associated with Clexio Biosciences Ltd., where she continues to develop her innovative ideas. Her work at the company reflects her dedication to improving healthcare outcomes through scientific research and innovation.
Collaborations
Ari collaborates with David Dangoor, who is also involved in the field of neuropsychiatry. Their partnership exemplifies the importance of teamwork in advancing medical research and developing effective treatment strategies.
Conclusion
Ari Gershon's contributions to the field of neuropsychiatry through her patent and work at Clexio Biosciences Ltd. demonstrate her commitment to improving patient care. Her innovative approach to treatment continues to inspire advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile